Stage I | Stage II | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample | Genotyping | Sample | Gender (%)a | Ageb | Genotyping | Sample | Gender (%)a | Ageb | ||||||||
Study | Population | Method | SNPs | Case | Control | Case | Control | Case | Control | Method | Case | Control | Case | Control | Case | Control |
Tse (2009) | Taiwan | Illumina Hap550 | 480,365 | 277 | 285 | 76 | 67 | 49 (12) | 50 (14) | TaqMan | 635 | 1,640 | 73 | 73 | 50 (13) | 59 (14) |
Bei (2010) | Guangdongc | Illumina Hap610 | 464,328 | 1,583 | 1,894 | 73 | 69 | 46 (11) | 47 (11) | TaqMan | 3,507 | 3,063 | 74 | 67 | 46 (12) | 44 (12) |
Tang (2012) | Guangxi and Guangdong | Affymatrix 6.0 | 591,458 | 567 | 476 | - | - | - | - | TaqMan | 923 | 1,105 | - | - | - | - |
Li (2011) | Guangdong | TaqMan | 233 | 360 | 360 | 72 | 34 | 46 (11) | 41 (9) | |||||||
Zhao (2012) | Guangdong | SNPstream | 100 | 206 | 180 | 71 | 67 | - | - | Sequenome | 535 | 525 | 73 | 76 | - | - |
Hsu (2012) | Taiwan | TaqMan | 12 | 337 | 286 | 70 | 70 | 46 | 46 | |||||||
Gao (2014) | Guangdong and Guangxi | TaqMan | 16 | 350 | 619 | 67 | 43 | 45 (11) | 46 (10) | TaqMan | 816 | 1721 | 73 | 61 | 45 (11) | 46 (12) |